X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (95) 95
humans (86) 86
male (51) 51
female (50) 50
thromboembolism (48) 48
aged (41) 41
venous thromboembolism (40) 40
middle aged (39) 39
pulmonary embolism (38) 38
hematology (31) 31
anticoagulants (29) 29
life sciences (29) 29
peripheral vascular disease (28) 28
adult (23) 23
diagnosis (23) 23
risk (23) 23
risk factors (23) 23
aged, 80 and over (22) 22
deep-vein thrombosis (22) 22
medicine, general & internal (22) 22
pulmonary-embolism (22) 22
anticoagulants - therapeutic use (21) 21
prevention (21) 21
analysis (20) 20
care and treatment (20) 20
management (20) 20
mortality (19) 19
thrombosis (19) 19
respiratory system (18) 18
treatment outcome (18) 18
cancer (17) 17
human health and pathology (17) 17
registries (17) 17
warfarin (16) 16
riete registry (15) 15
survival (15) 15
venous thrombosis (15) 15
abridged index medicus (14) 14
guidelines (14) 14
prognosis (14) 14
recurrence (14) 14
health risk assessment (13) 13
patients (13) 13
risk-factors (13) 13
anticoagulants - administration & dosage (12) 12
bleeding (12) 12
cardiac & cardiovascular systems (12) 12
dabigatran (12) 12
internal medicine (12) 12
disease (11) 11
pulmonary hypertension (11) 11
young adult (11) 11
embolism (10) 10
heparin (10) 10
pulmonary embolism - diagnosis (10) 10
pulmonary embolism - epidemiology (10) 10
rivaroxaban (10) 10
usage (10) 10
venous thromboembolism - epidemiology (10) 10
administration, oral (9) 9
anticoagulant therapy (9) 9
anticoagulants - adverse effects (9) 9
embolisms (9) 9
hematology, oncology and palliative medicine (9) 9
hemorrhage - chemically induced (9) 9
hypertension (9) 9
metaanalysis (9) 9
prospective studies (9) 9
research (9) 9
retrospective studies (9) 9
therapy (9) 9
venous thromboembolism - drug therapy (9) 9
venous thrombosis - epidemiology (9) 9
arterial-hypertension (8) 8
cardiology (8) 8
cardiology and cardiovascular system (8) 8
drug therapy (8) 8
fibrinolytic agents - therapeutic use (8) 8
follow-up studies (8) 8
fondaparinux (8) 8
health aspects (8) 8
medical research (8) 8
medicine (8) 8
pulmonary embolism - mortality (8) 8
antithrombotic therapy (7) 7
cohort studies (7) 7
d-dimer (7) 7
medicine, experimental (7) 7
outcomes (7) 7
patient outcomes (7) 7
pharmacology & pharmacy (7) 7
population (7) 7
prophylaxis (7) 7
pulmonary embolism - complications (7) 7
risk assessment (7) 7
ultrasonography (7) 7
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (6) 6
adolescent (6) 6
atrial-fibrillation (6) 6
deep vein thrombosis (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The European respiratory journal, ISSN 0903-1936, 07/2017, Volume 50, Issue 1, pp. 1700959 - 1700959
Chronic obstructive pulmonary disease (COPD) is recognised as a moderate risk factor (odds ratio between 2 and 9) for venous thromboembolism (VTE) [1], in the... 
RIETE REGISTRY | POPULATION | VENOUS THROMBOEMBOLISM | THROMBOSIS | RESPIRATORY SYSTEM | DISEASE | RISK | Humans | Pulmonary Disease, Chronic Obstructive | Pulmonary Embolism | Embolisms | Pulmonary arteries | Lung diseases | Obstructive lung disease | Chronic obstructive pulmonary disease | Thorax | Thromboembolism | Health risk assessment | Embolism | Cancer
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 16, pp. 1675 - 1683
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 12, pp. 1536 - 1544
Abstract Background The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is unknown. Objectives This study investigated the long-term... 
Cardiovascular | Internal Medicine | chronic thromboembolic pulmonary hypertension | thrombolysis | long-term survival | pulmonary embolism | prognosis | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | CARDIOLOGY ESC | EUROPEAN-SOCIETY | TIME TRENDS | TRIAL | TASK-FORCE | HYPERTENSION | Pulmonary Embolism - prevention & control | Echocardiography | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Pulmonary Embolism - mortality | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy | Aged, 80 and over | Female | Aged | Tenecteplase | Pulmonary Embolism - diagnostic imaging | Pulmonary embolism | Stroke (Disease) | Medicine, Experimental | Medical research | Cardiology | Cardiovascular agents | Heart | Therapy | Chest | Incidence | Design | Computed tomography | Motivation | Tomography | Diagnosis | Thromboembolism | Anticoagulants | Pulmonary arteries | Mortality | Statistical tests | Patients | Fibrinolysis | Survival | Computation | Diagnostic software | Death | Health risk assessment | Risk management | Angiography | Arches | Embolisms | Medical services | Clinical trials | Population studies | Hemorrhage | Bleeding | Guidelines | Reperfusion | Risk assessment | Calcium-binding protein | Trends | Heart diseases | Injuries | Hypertension | Collapse | Stroke | Statistical analysis | Receiving | Complications | Risk reduction | Statistics | Pulmonary hypertension | Embolism | Computer programs | Contact | Thromboplastin | Medical prognosis | Fatalities | Ventricle | Heparin | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Cerebrovascular diseases (Basel, Switzerland), ISSN 1015-9770, 09/2019, pp. 1 - 6
Cerebral venous thrombosis (CVT) is an uncommon neurological condition usually treated with heparin followed by oral vitamin K antagonists (VKAs). In patients... 
Journal Article
Respiration, ISSN 0025-7931, 05/2013, Volume 85, Issue 6, pp. 452 - 455
  Pulmonary hypertension (PH) is relatively frequent in patients with advanced chronic respiratory disorders including IPF [7] and other chronic lung diseases... 
Editorial | SURVIVAL | LUNG | PRESSURE | CAPACITY | SILDENAFIL | RESPIRATORY SYSTEM | ARTERIAL-HYPERTENSION | EMPHYSEMA | PREDICTION | Hypertension, Pulmonary - diagnosis | Idiopathic Pulmonary Fibrosis - complications | Hypertension, Pulmonary - etiology | Humans | Hypertension | Pulmonary arteries
Journal Article
Journal Article
Journal Article
La Revue du praticien, ISSN 0035-2640, 02/2015, Volume 65, Issue 2, pp. 193 - 198
Journal Article
La Revue du praticien, ISSN 0035-2640, 02/2015, Volume 65, Issue 2, p. 193
The initial management or venous thromboembolism (VTE) corresponds to the first 3 months of treatment. Pulmonary embolism (PE) are mostly hospitalized. Serious... 
Pulmonary Embolism - prevention & control | Vitamin K - antagonists & inhibitors | Risk Assessment | Fibrinolytic Agents - therapeutic use | Humans | Blood Coagulation Tests | Anticoagulants - therapeutic use | Venous Thromboembolism - drug therapy
Journal Article
Immunity, ISSN 1074-7613, 07/2012, Volume 37, Issue 1, pp. 60 - 73
Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8 T cell responses. Several... 
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2018, Volume 365, Issue 3, pp. 519 - 525
Because of their lower bleeding risk and simplicity of use, direct oral anticoagulants (DOACs) could represent an interesting alternative to conventional... 
Journal Article
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 1/2019, Volume 47, Issue 1, pp. 96 - 101
A clinical score was recently proposed to rule out concomitant DVT in patients with a clinical suspicion of SVT. This study aimed to assess the external... 
Pulmonary embolism | Medicine & Public Health | Hematology | Saphenous vein | Ultrasonography | Venous thrombosis | Cardiology | Risk factors | DIAGNOSIS | FONDAPARINUX | LEGS | LOWER-LIMBS | PREVALENCE | PULMONARY-EMBOLISM | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CONCURRENT | Data processing | Compression | Patients | Thrombosis
Journal Article